Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
CBAB 20(2) 2020
CBAB 20(1) 2020
Editions
Uncategorized
CBAB 19(4) 2019
CBAB 19(3) 2019
CBAB 19(2) 2019
CBAB 19(1) 2019
CBAB 18(4) 2018
CBAB 18(3) 2018
CBAB 18(2) 2018
CBAB 18(1) 2018
CBAB News
CBAB 17(4) 2017
CBAB 17(3) 2017
CBAB 17(2) 2017
CBAB 17(1) 2017
CBAB 16(4) 2016
CBAB 16(3) 2016
CBAB 16(2) 2016
CBAB 16(1) 2016
CBAB 15(4) 2015
CBAB 15(3) 2015
CBAB 15(2) 2015
CBAB 15(1) 2015
CBAB 14(4) 2014
CBAB 14(3) 2014
CBAB 14(2) 2014
CBAB 14(1) 2014
CBAB 13(4) 2013
CBAB 13(3) 2013
CBAB 13(2) 2013
CBAB 13(1) 2013
CBAB 12(S2) 2012 Special Edition
CBAB 12(4) 2012
CBAB 12(3) 2012
CBAB 12(2) 2012
CBAB 12(1) 2012
CBAB 11(S1) 2011 Special Edition
CBAB 11(4) 2011
CBAB 11(3) 2011
CBAB 11(2) 2011
CBAB 11(1) 2011
CBAB 10(4) 2010
CBAB 10(3) 2010
CBAB 10(2) 2010
CBAB 10(1) 2010
CBAB 09(4) 2009
CBAB 09(3) 2009
CBAB 09(2) 2009
CBAB 09(1) 2009
CBAB 08(4) 2008
CBAB 08(3) 2008
CBAB 08(2) 2008
CBAB 08(1) 2008
CBAB 07(4) 2007
CBAB 07(3) 2007
CBAB 07(2) 2007
CBAB 07(1) 2007
CBAB 06(4) 2006
CBAB 06(3) 2006
CBAB 06(2) 2006
CBAB 06(1) 2006
CBAB 05(4) 2005
CBAB 05(3) 2005
CBAB 05(2) 2005
CBAB 05(1) 2005
CBAB 04(4) 2004
CBAB 04(3) 2004
CBAB 04(1) 2004
CBAB 03(4) 2003
CBAB 03(3) 2003
CBAB 03(2) 2003
CBAB 03(1) 2003
CBAB 02(4) 2002
CBAB 02(3) 2002
CBAB 02(2) 2002
CBAB 02(1) 2002
CBAB 01 (4) 2001
CBAB 01 (3) 2001
CBAB 01 (2) 2001
CBAB 01 (1) 2001
+55 31 3612-4490
cbabjournal@gmail.com
Close

Anésio Bianchini, Juliana Sawada Buratto, Nelson da Silva Fonseca Júnior, Vânia Moda-Cirino and Solange Monteiro de Toledo Piza Gomes Carneiro

Abstract: IPR Celeiro is a common bean (Phaseolus vulgaris L.) cultivar with
a carioca-type seed and moderate resistance to Bean Golden Mosaic Virus
(BGMV). IPR Celeiro has a normal life cycle and an upright architecture. This
cultivar was released for the purpose of integrating its use with disease management
systems in the cultivation areas affected by this virus.

Get the article here. (PDF)

Add Your Comment

Your email address will not be published. Required fields are marked *